Our Science

Biocodex develops, manufactures and distributes world-class pharmaceutical products and health solutions for patients in more than 120 countries. Focusing on three main pillars (microbiota mission, orphan drugs and women’s health), we combine in house R&D and scientific partnerships, production expertise, and investments in start-ups to remain at the forefront of innovation and quality.

R&D Center

Biocodex has its own integrated Research and Development center in Compiegne (France). Internal research requires in-depth knowledge of all our medicines and health products, which enables us to evaluate their impact and carry out projects relating to therapeutic innovation.
R&D Center
Main entrance of Biocodex R&D center in Compiègne (Oise), France

Our facilities

Biocodex operates three manufacturing facilities in France and Morocco in compliance with the highest standards to guarantee product quality and safety.
Our facilities
Main entrance of Biocodex industrial facilities in Beauvais (Oise, France.

Investing in start-ups

Biocodex has invested in start-ups since 2016 and become a key player in the French biotech ecosystem. We focus mainly on companies developing medical unmet needs and innovative therapeutics from probiotics, or microbial strains that are beneficial to health. With its long-term approach and industrial expertise, Biocodex is recognized as a valuable partner by CEOs, project owners and traditional investors, such as fund managers. Biocodex is always looking to support new meaningful projects.
Investing in start-ups
A group of four people wearing suits sitting in individual sits by a bow window and talking to each other